Entries tagged with “gene-therapy”

Articles

6 articles found for gene-therapy:

  • Gene Therapy: Revolutionizing Type 1 Diabetes Care

    Type 1 diabetes results from intricate interactions between genetic predisposition and environmental triggers. Existing treatments often fall short of providing sustained relief, prompting the search for alternative solutions. Gene therapy offers such avenues by either reprogramming alpha cells to perform beta cell function or providing gene editing tools that cut out damaged DNA altogether. The landscape of cell and gene therapy is ever evolving, accelerated by substantial investments, novel technology, and strategic partnerships among key major players. Cutting-edge technology, regulatory backing, and favorable market conditions are propelling alternative therapies towards mainstream acceptance.

  • Cell and Gene Therapy – The Next Frontier in Lifesciences

    In this era of rapid scientific and technological advancements, we are at the precipice of a healthcare revolution. Cell and Gene therapy (CGT), pioneering treatments that leverage our own biology, are poised to challenge traditional healthcare frameworks. CGT has been witnessing an expanding total addressable market and is expected to grow exponentially. However, the potential gains are not merely financial. Investments in this growing field also help propel the momentum of scientific and medical progress, funding vital research that brings us closer to a more efficient, personalized, and holistic healthcare future. This article attempts to present the current and future landscape of CGT, with a focus on the clinical pipeline evolution, strategic collaborations, and financing and investment environment globally. 

  • Deciphering the Complex Etiology of Type 1 Diabetes

    Type 1 diabetes (T1D) is a complex autoimmune disease with a multifactorial etiology. Genetic predisposition, environmental triggers, and immune dysregulation contribute to the development of this chronic condition. Diagnoses involves a combination of clinical evaluation, laboratory tests, and medical history assessment. T1D impacts millions globally, with its incidence rising notably among African American and Hispanic youth populations. A variety of treatment options, including maintenance therapy, transplants, gene therapy, vaccines, antibodies, and combination therapies, are being explored to improve outcomes and quality of life for individuals with T1D.

  • Latest Trends in Regenerative Medicine

    Healthcare and medicine are in a constant state of evolution. Innovative technologies such as regenerative medicine are bringing about a paradigm shift in the healthcare industry. While the segment does raise some moral questions, it is witnessing huge capital infusion from pharmaceutical companies. Despite the major challenges associated with regenerative medicine, industry trends indicate that it is poised for growth.

  • CRISPR Therapeutics – Transforming Healthcare

    CRISPR technology has been gaining prominence as a realistic treatment option for genetic diseases. Major recent licensing activity is seen from pharmaceutical companies that are also investing in startups in this domain. While technology could revolutionize healthcare, especially for genetic diseases, it has its shortcomings and research is ongoing to address them for wider adoption of CRISPR.

  • CRISPR Technology – An Emerging Solution in Healthcare

    CRISPR technology has been gaining growing acceptance and popularity in the healthcare sector. Its varied applications in medical science has fostered innovations, with many startups entering the fray. However, CRISPR is a complex concept, and the technology is still at the nascent stage of development. Many new applications are under trials and await approval for launch. Moreover, the technology is marred with some underlying ethical issues. A strong regulatory framework will ensure the appropriate use of CRISPR.